APA (7th ed.) Citation

Zenklusen, I., Hsin, C., Schilling, U., Kankam, M., Krause, A., Ufer, M., & Dingemanse, J. (2022). Transition from Syringe to Autoinjector Based on Bridging Pharmacokinetics and Pharmacodynamics of the P2Y12 Receptor Antagonist Selatogrel in Healthy Subjects. Clinical pharmacokinetics, 61(5), 687-695. https://doi.org/10.1007/s40262-021-01097-9

Chicago Style (17th ed.) Citation

Zenklusen, Isabelle, Chih-Hsuan Hsin, Uta Schilling, Martin Kankam, Andreas Krause, Mike Ufer, and Jasper Dingemanse. "Transition from Syringe to Autoinjector Based on Bridging Pharmacokinetics and Pharmacodynamics of the P2Y12 Receptor Antagonist Selatogrel in Healthy Subjects." Clinical Pharmacokinetics 61, no. 5 (2022): 687-695. https://doi.org/10.1007/s40262-021-01097-9.

MLA (9th ed.) Citation

Zenklusen, Isabelle, et al. "Transition from Syringe to Autoinjector Based on Bridging Pharmacokinetics and Pharmacodynamics of the P2Y12 Receptor Antagonist Selatogrel in Healthy Subjects." Clinical Pharmacokinetics, vol. 61, no. 5, 2022, pp. 687-695, https://doi.org/10.1007/s40262-021-01097-9.